Navigation Links
Use of Clinical Endpoint Adjudication Committees Finding Increasing Favor with Regulators
Date:3/28/2011

BALA CYNWYD, Pa., March 28, 2011 /PRNewswire/ -- Applied Clinical Intelligence, LLC (ACI), an industry leader in clinical endpoint adjudication committees and independent data monitoring committees (www.icommittees.com), announces the opening of registration for a complimentary breakfast seminar in Cambridge, MA. The 90-minute seminar will focus on aligning independent expert committees with development goals.  This is a unique opportunity to learn practical advice about effective design and management of Clinical Endpoint Committees (CECs) and Endpoint Adjudication Committees (EACs).

"The regulatory pressure for independent adjudication of composite endpoints is escalating, and we want to make sure that those involved in drug, biotech, and device development understand the potential regulatory issues," said Dr. Jonathan Seltzer, MD, MBA, FACC, President and CEO of ACI.  Please join us for this unique learning opportunity.  For your convenience, the seminar is being offered on both April 5th and April 6th in Cambridge, MA from 8:30 a.m. to 10 a.m. ACI will also host seminars in different regions over the next few months.  Registration details for this complimentary seminar are available at http://www.a-ci.com/index.php?id=62.

Topics will include:

  • Practical issues with adjudication of Composite Endpoints and MACE
  • Regulatory strategy for Clinical Endpoint Adjudication
  • Independent Expert Compensation and Sunshine Laws
  • Issues with Image Adjudication presented by Intrinsic Imaging (www.intrinsiccro.com)

Please also visit our iCommittees™ website for more information: www.icommittees.com.

About Applied Clinical Intelligence

ACI provides integrated and highly efficient risk reduction solutions for clinical research.  iCommittees™ is a comprehensive, independent expert committee solution offering management, regulatory-grade biostatistical support, automated processes and documentation expertise for Data Monitoring Committees (DSMBs) and EACs.  Founded in 2001, ACI is headquartered in the Philadelphia area and has deployed its automated solutions to hundreds of trials in over 50 countries.  For more information, please visit www.a-ci.com.

Contact:
Kelly Ryan
484-429-7200


'/>"/>
SOURCE Applied Clinical Intelligence, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):